Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1113433
Name of medicinal product: Cefaximin-L
Active substances:
Cefacetrile+Rifaximin
Estonian, English, Latin
ATC code: QJ51RD84
Dosage form: intramammary emulsion
Route of administration: intramammary use
Strengh: 12,52mg+6,66mg 1g
Amount in package: 15g 4TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Treatment of intramammary infections in lactating cows caused by microorganisms sensitive to rifaximin and cefacetril. Clinically relevant spectrum of activity:Str. agalactiae, Str. uberis, Str. dysgalactiae, Enterococcus faecalis, Str. zooepidemicus; S. aureus, including penicillin-resistant strains, S. epidermidis; Trueperella pyogenes.
Safety features: No
Summary of product characteristics (SPC):  (last updated February 28, 2023)
Package information leaflet (PIL): EST  (last updated February 28, 2023)
Labelling:  (last updated February 28, 2023)
Withdrawal time: Lihale ja söödavatele kudedele: 5 päeva. Piimale: 60 tundi.
Species: veis
Last imported to Estonia: September 27, 2023
Marketing authorization holder: Fatro S.p.A. 
Marketing authorization number: 1127 
Marketing authorization issued on: October 4, 2002 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: National 
Entry/Changing date: February 28, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere